Boceprevir for chronic HCV genotype 1 infection.

  title={Boceprevir for chronic HCV genotype 1 infection.},
  author={Alpna R. Limaye and Peter Draganov and R. Herruzo Cabrera},
  journal={The New England journal of medicine},
  volume={365 2},
  pages={176; author reply 177-8}
To the Editor: Poordad et al. and Bacon et al. (March 31 issue)1,2 report improved rates of sustained virologic response among patients with chronic infection with the hepatitis C virus (HCV) who received boceprevir. Although these rates are similar to those seen among patients who received telaprevir,3-5 the telaprevir studies did not allow erythropoietin use, so there are important distinctions between the two protease inhibitors. In the boceprevir studies, despite erythropoietin use in 41 to… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 16 extracted citations

Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2012
View 5 Excerpts
Highly Influenced

Molecular characterization of hepatitis C virus genotype 6 subtypes in Thai blood donors.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi • 2017

Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2016
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 11 references

Genetic variation in IL28B The New England Journal of Medicine Downloaded from at N C

D Ge, J Fellay, AJ Thompson
STATE UNIVERSITY on December • 2012

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2011

IL28B polymorphism predicts virologic response in patients with hepatitis C genotype 1 treated with boceprevir (Boc) combination therapy

F Poordad, J-P Bronowicki, S Gordon
Presented at Digestive Disease Week, • 2011

Similar Papers

Loading similar papers…